Cantargia AB (publ) (7V3.F)
| Previous Close | 0.2538 |
| Open | 0.2482 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2482 - 0.2602 |
| 52 Week Range | 0.2082 - 0.5030 |
| Volume | |
| Avg. Volume | 102 |
| Market Cap | 53.843M |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1400 |
| Earnings Date | May 21, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Cantargia Publishes Annual Report for 2023
LUND, SE / ACCESSWIRE / April 18, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today announced that the annual report for 2023 has been published. The Annual Report and the European Single Electronic Format (ESEF) ...
- ACCESSWIRE
Notice of Annual General Meeting in Cantargia AB (publ)
LUND, SWEDEN / ACCESSWIRE / April 18, 2024 / Cantargia (STO:CANTA) The shareholders of Cantargia AB (publ) are invited to the annual general meeting on Thursday, 23 May 2024, at 15.00 CEST at Ideon Gateway, Scheelevägen 27, Lund, Sweden. Right to ...
- ACCESSWIRE
Cantargia Publishes New Data on the CAN10 Antibody, Detailing its Interaction with IL1RAP and Functional Inhibition
LUND, SE / ACCESSWIRE / April 17, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported publication of new preclinical data in the highly reputable scientific journal Cell Reports on the clinical stage antibody ...
